Taken together, these results clearly suggest that early intensification of ... including complete cytogenetic and molecular response in over 80% of CML patients in the chronic phase.

This section will focus on disease and therapy-related factors, which could predict response in newly diagnosed CP-CML patients ... Comparison of 12-month major molecular response rates with ...

Molecular response is one of the ways that doctors monitor the effectiveness of a CML treatment ... In September, Terns reported an early-stage trial of its obesity treatment in pill form ...

BCR::ABL1 Deep Molecular Response Quantification and Transcript Type Identification in Chronic Myeloid Leukemia Using a US Food and Drug Administration–Approved Droplet-Based Digital PCR Assay ...

Dr. Westerweel concludes, “Digital PCR for BCR::ABL is a valuable and reliable tool to aid clinical decision making in CML.” BCR::ABL1 Deep Molecular Response Quantification and Transcript ...